In agreement, the CSF/blood ratios of HLA-DR+ T cells is significantly increased in both MS subtypes and also in OIND and, for HLA-DR+/CD4+ T cells, weakly but significantly also in NIND controls. Here, CD4 is linked to myeloid sarcoma.